Metoclopramide protection of cholinesterase from paraoxon inhibition

Veterinary and Human Toxicology

Volumn 45, Issue 5, 2003, Pages 251-253

  Petroianu, Georg A ^b   Hasan, Mohd Y ^b   Kosanovic, Melita ^b   Vijayasarathy, C ^a   Saleh, A M ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE INHIBITOR; METOCLOPRAMIDE; PARAOXON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLINESTERASE INHIBITION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG CROSS REACTIVITY; DRUG MECHANISM; ENZYME ACTIVITY; ERYTHROCYTE KINETICS; EVALUATION; IN VIVO STUDY; INHIBITION KINETICS; MALE; NONHUMAN; PROTECTION; RANK SUM TEST; RAT; STATISTICAL SIGNIFICANCE;

ACETYLCHOLINESTERASE; ANIMALS; CHOLINESTERASE INHIBITORS; CHOLINESTERASE REACTIVATORS; ERYTHROCYTES; HUMANS; MALE; METOCLOPRAMIDE; PARAOXON; RANDOM ALLOCATION; RATS;

ANIMALIA;

EID: 0141520659     PISSN: 01456296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. R. Levine: Recognized and possible effects of pesticides in humans. In WJ Hayes, ER Laws: Handbook of Pesticide Toxicology, General Principles, Vol 1, Academic Press, San Diego: 275-360, 1991.
2. Petroianu G, Toomes LM, Petroianu A et al: Control of blood pressure, heart rate and haematocrit during high-dose intravenous Paraoxon exposure in mini pigs. J Appl Toxicol 18: 293-298,1998.
3. Johnson MK, Jacobsen D, Meredith TJ et al: Evaluation of antidotes for poisoning by organophosphourus pesticides. Emerg Med 12: 22-37, 2000.
4. Sidell FR, Groff WA, Kaminskis A: Pralidoxime Methanesulfonate, Plasma levels and pharmacokinetics after oral administration to man. J Pharm Sci 61:1136-1140, 1972.
5. Swartz RD, Sidell FR: Effects of heat and exercise on the elimination of pralidoxime in man. Clin Pharmacol Ther 14: 83-89, 1973.
6. nd Ed Pharmaceutical Press, Taunton, Massachussetts: 992-993, 1999.
7. Van Helden HP, Busker RW, Melchers BPC et al: Pharmacological effects of oximes: how relevant are they? Arch Toxicol 70: 779-786, 1996.
8. Peter JV, Cherian AM: Organic insecticides. Anaesth Intensive Care 28: 11-21, 2000.
9. Maleck W, Kern N, Beha U et al: Iv-L-lactate application in minipigs partially protects acetyl-cholinesteratic, but not butyrylcholinesteratic activity in plasma from inhibition by paraoxon. Crit Care Med 30: 1547-1552, 2002.
10. Petroianu G, Ewald V, Thyes C et al: Iv-pyruvic acid application in minipigs partially protects acetylcholine-esteratic, but not butyrylcholineesteratic activity in plasma from inhibition by paraoxon. J Appl Toxicol 23:37-42, 2003.
11. Graham SG, Crossley AWA: The characteristics of the inhibition of serumcholinesterase by metoclopramide. Eur J Clin Pharmacol 48: 25-228, 1995.
12. Chemnitius JM, Haselmeyer KH, Gonska BD et al: Indirect parasympathomimetic activity of Metoclopramide: Reversible inhibition of cholinesterases from human central nervous system and blood. Pharmacological Research 34: 65-72, 1996.
13. Ross-Lee LM, Eadie M J, Hooper W D et al: Single-dose pharmacokinetics of Metoclopramide. Eur J Clin Pharmacol 20: 465-471, 1981.
14. Petroianu G, Kühn F, Thyes C et al: In vitro protection of plasma cholinesterases by metoclopramide from inhibition by paraoxon. J Appl Toxicol 23: 75-79, 2003.
15. McGovern EM, Grevel J, Bryson SM: Pharmacokinetics of high-dose Metoclopramide in cancer patients. Clin Pharmacokinet 11: 415-424, 1986.
16. Worek F, Mast U, Kiderlen D et al: Improved determination of acetylcholinesterase activity in human whole blood. Clin Chim Acta 288: 73-90, 1999.
17. Van Kampen EJ, Zijlstra WG: Standardization of hemoglobinometry II. The hemoglobincyanide method. Clin Chim Acta 6: 538-544, 1961.
18. Dawson JD, Lagakos SW: Size and power of two sampled tests of repeated measures data. Biometrics 49: 1022-1023, 1993.
19. Petroianu G, Altmannsberger S, Maleck W et al: Centrifugated autologous amniotic fluid infusion: effects on coagulation in pregnant minipigs. Crit Care Med 27: 348-3551999.
20. Dart RC, Goldfrank LR, Chyka PA et al: Combined evidence-based literature analysis and consensus guidelines for stocking of emergency antidotes in the United States. Ann Emerg Med 36: 126-132, 2000.
21. Geldmacher-von Mallinkrodt M, Urbach HJ, Kittel H et al: Zur Messung der in vivo und in vitro Reaktivierbarkeit alkylphosphat-vergifteter Serumcholinesterase durch 2-PAM und Toxogonin mit verschiedenen Substanzen. Z Klin Chem Klin Bioochem 7: 480-485, 1969.
22. Pannbacker RG, Oehme FW: Pralidoxime hydrolysis of thiocholine esters. Vet Hum Toxicol 45: 39-40, 2003.
23. Zuleger K, Thyes C, Ewald V et al: Pralidoxime (PRX) induces significant pseudo-activity in vivo (mini-pig). Anesth Analg 94: S-324, 2002 (abstract).